Citric Acid; Lactic Acid; Potassium Bitartrate Patent Expiration

Citric Acid; Lactic Acid; Potassium Bitartrate is used for contraception. It was first introduced by Evofem Inc in its drug Phexxi on May 22, 2020.


Citric Acid; Lactic Acid; Potassium Bitartrate Patents

Given below is the list of patents protecting Citric Acid; Lactic Acid; Potassium Bitartrate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Phexxi US10568855 Compositions and methods for enhancing the efficacy of contraceptive microbicides Mar 15, 2033 Evofem Inc
Phexxi US11337989 Compositions and methods for inhibiting inflammation and diseases using an alginic acid-based antimicrobial compound Mar 15, 2033 Evofem Inc
Phexxi US11439610 Compositions and methods for enhancing the efficacy of contraceptive microbicides Mar 15, 2033 Evofem Inc
Phexxi US11992472 Compositions and methods for enhancing the efficacy of contraceptive microbicides Mar 15, 2033 Evofem Inc
Phexxi US6706276 Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa Mar 06, 2024

(Expired)

Evofem Inc



Citric Acid; Lactic Acid; Potassium Bitartrate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List